Inhibitors of the blood coagulation process in patients with essential thrombocythemia.

Ziolkowska, Katarzyna; Boinska, Joanna; Gadomska, Grazyna; Wieczór, Radoslaw; Rosc, Danuta

Ziolkowska, Katarzyna; Boinska, Joanna; Gadomska, Grazyna; Wieczór, Radoslaw; Rosc, Danuta.

Affiliation

Ziolkowska K; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus, University in Torun, Collegium Medicum in Bydgoszcz.
Boinska J; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus, University in Torun, Collegium Medicum in Bydgoszcz.
Gadomska G; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus, University in Torun, Collegium Medicum in Bydgoszcz.
Wieczór R; Clinic of Vascular and Internal Medicine, Dr Jan Biziel University Hospital No. 2, Bydgoszcz, Poland.
Rosc D; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus, University in Torun, Collegium Medicum in Bydgoszcz.

Blood Coagul Fibrinolysis ; 31(3): 219-224, 2020 Apr.

Article de En | MEDLINE | ID: mdl-32108679

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Coagulation sanguine / Thrombocytémie essentielle Type d'étude: Risk_factors_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: Blood Coagul Fibrinolysis Sujet du journal: ANGIOLOGIA / HEMATOLOGIA Année: 2020 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google